Curaleaf Holdings (CURLF) Current Deferred Revenue (2022 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Current Deferred Revenue of $3.0 million for Q4 2025, down 91.03% year-over-year from $33.1 million in Q4 2024, and down 91.03% quarter-over-quarter from $33.1 million in Q4 2024.
Curaleaf Holdings (CURLF) Current Deferred Revenue (2022 - 2026) Analysis & Trends
Curaleaf Holdings' Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Current Deferred Revenue fell 91.03% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (down 91.03% YoY), while the FY2025 annual figure was $3.0 million, down 91.03% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $3.0 million, down from $33.1 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $33.1 million in Q4 2024, with the low at $3.0 million in Q4 2025.
- The 4-year median for Current Deferred Revenue is $23.5 million (2022), against an average of $21.8 million.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue jumped 48.01% in 2024, then slumped 91.03% in 2025.
- Curaleaf Holdings' Current Deferred Revenue stood at $24.4 million in 2022, then retreated by 8.61% to $22.3 million in 2023, then surged by 48.01% to $33.1 million in 2024, then plunged by 91.03% to $3.0 million in 2025.
- Business Quant data shows CURLF's Current Deferred Revenue at $3.0 million in Q4 2025, $33.1 million in Q4 2024, and $22.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.24 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 33.07 Mn |
| Sep 30, 2024 | 22.64 Mn |
| Jun 30, 2024 | 25.41 Mn |
| Dec 31, 2023 | 22.34 Mn |
| Dec 31, 2022 | 24.45 Mn |